Skip to main content

Pharmacological Review of Benzodiazepines

Tracking # 20-1323234

$24.99

5 (7 ratings)
CE Broker Reporting Reported automatically
Method Computer-Based Training

What you'll learn

Upon completion of this course, learners will have met the following learning objectives:

  1. Describe the mechanism of action of benzodiazepines at the GABAA receptor, including the role of a and ¿ subunits in modulating inhibitory neurotransmission.
  2. Differentiate benzodiazepines based on their pharmacokinetic properties—lipophilicity, metabolic pathway, half-life, and presence of active metabolites—and explain how they influence onset, duration, and clinical effect.
  3. Analyze clinical scenarios to determine the safest benzodiazepine choice for clients with hepatic or renal impairment, considering both metabolism and elimination pathways.
  4. Evaluate the risks and benefits of benzodiazepine therapy in various populations—including older adults, pregnant or breastfeeding clients, and individuals with substance use disorders—while applying evidence-based prescribing principles.
  5. Develop individualized prescribing and monitoring plans that minimize the risk of dependence, withdrawal, and adverse drug interactions, particularly with other central nervous system depressants such as opioids or alcohol.

Course overview

This course provides an in-depth exploration of benzodiazepines, a class of lipophilic Schedule IV agents essential in acute and select chronic conditions such as seizure control, procedural sedation, severe anxiety, and alcohol withdrawal. Learners will examine the mechanisms of action of GABAA receptors, receptor subunit selectivity, pharmacokinetics, and pharmacogenomic considerations that influence drug choice, dosing, and duration. The curriculum addresses therapeutic indications, routes of administration, metabolic pathways, and the impact of hepatic or renal impairment, while recognizing risk mitigation for dependence, withdrawal, and life-threatening interactions with other CNS depressants. Through a case study and evidence-based guidance, participants will develop the skills to select the most appropriate benzodiazepine, tailor therapy to individual patient profiles, monitor for adverse effects, and apply safe discontinuation strategies in clinical practice.

Subject areas

This course counts toward the state boards and subject areas below.

Arkansas State Board of Nursing

Certified Nurse Midwife

3h Pharmacotherapeutics continuing education in the area of certification

Certified Nurse Practitioner

3h Pharmacotherapeutics continuing education in the area of certification

Certified Registered Nurse Anesthetist

3h Pharmacotherapeutics continuing education in the area of certification

Clinical Nurse Specialist

3h Pharmacotherapeutics continuing education in the area of certification

Registered Nurse Practitioner

3h Practice-Focused Continuing Education

Dermatology Nurse Practitioner Certification Board

Dermatology Certified Nurse Practitioner

3h Dermatology Contact Hours

District of Columbia Board of Nursing

Certified Nurse Midwife

3h Pharmacology Component

Clinical Nurse Specialist

3h Pharmacology Component

Nurse Practitioner

3h Pharmacology Component

Registered Nurse Anesthetist

3h Pharmacology Component

Florida Board of Nursing

APRN Temporary Certificate for Practice in Areas of Critical Need

3h General

Advanced Practice Registered Nurse

3h Pharmacology for Autonomous Practice Initial Certification

Kansas State Board of Nursing

Clinical Nurse Specialist

3h Approved CNE Related to the Advanced Practice Registered Nurse

Licensed Mental Health Technician

3h Continuing Nursing Education (CNE)

Licensed Practical Nurse

3h Approved CNE Related to the Advanced Practice Registered Nurse

Nurse Midwife

3h Approved CNE Related to the Advanced Practice Registered Nurse

Nurse Practitioner

3h Approved CNE Related to the Advanced Practice Registered Nurse

Registered Nurse Anesthetist

3h Approved CNE Related to the Advanced Practice Registered Nurse

Mississippi Board of Nursing

Certified Nurse Midwife

3h Prescribing Controlled Substances

Certified Registered Nurse Anesthetist

3h Prescribing Controlled Substances

Nurse Practitioner

3h Prescribing Controlled Substances

New Hampshire Board of Nursing

Advanced Practice Registered Nurse

3h Pharmacology

New Mexico Board of Nursing

Certified Nurse Practitioner

3h Continuing education related to pharmacology

Certified Registered Nurse Anesthetist

3h Continuing education related to pharmacology

Clinical Nurse Specialist

3h Continuing education related to pharmacology

North Dakota Board of Nursing

Advanced Practice Registered Nurse

3h Pharmacotherapy Related to Scope of Practice

South Carolina Board of Nursing

Advanced Practice Registered Nurse

3h Pharmacotherapeutics

Tennessee Board of Nursing

Advanced Practice Registered Nurse

3h General

Medication Aide

3h Pharmacology

West Virginia Board of Registered Nurses

Advanced Practice Registered Nurse

3h Prescriptive Authority Privilege (RXA) pharmacotherapeutic

Wyoming Board of Nursing

Certified Nurse Midwife

3h CE related to the responsible prescribing of controlled substances or treatment of substance abuse disorders

Certified Nurse Practitioner

3h CE related to the responsible prescribing of controlled substances or treatment of substance abuse disorders

Certified Nurse Specialist

3h CE related to the responsible prescribing of controlled substances or treatment of substance abuse disorders

Certified Registered Nurse Anesthetist

3h CE related to the responsible prescribing of controlled substances or treatment of substance abuse disorders

Licensed Practical Nurse

3h CE related to the responsible prescribing of controlled substances or treatment of substance abuse disorders

Registered Nurse

3h CE related to the responsible prescribing of controlled substances or treatment of substance abuse disorders

Disclosure statements

Use of Course Content. The courses provided by NCC are based on industry knowledge and input from professional nurses, experts, practitioners, and other individuals and institutions. The information presented in this course is intended solely for the use of healthcare professionals taking this course, for credit, from NCC. The information is designed to assist healthcare professionals, including nurses, in addressing issues associated with healthcare. The information provided in this course is general in nature and is not designed to address any specific situation. This publication in no way absolves facilities of their responsibility for the appropriate orientation of healthcare professionals. Hospitals or other organizations using this publication as a part of their own orientation processes should review the contents of this publication to ensure accuracy and compliance before using this publication. Knowledge, procedures or insight gained from the Student in the course of taking classes provided by NCC may be used at the Student’s discretion during their course of work or otherwise in a professional capacity. The Student understands and agrees that NCC shall not be held liable for any acts, errors, advice or omissions provided by the Student based on knowledge or advice acquired by NCC. The Student is solely responsible for his/her own actions, even if information and/or education was acquired from a NCC course pertaining to that action or actions. By clicking “complete” you are agreeing to these terms of use.

Take it Here

  • This course reports to CE Broker immediately upon completion.
  • Complete all courses at your own pace online.
  • Quality and enjoyable courses.
  • Modern experience, accessible from any device.
  • All courses affordably priced.

Learner Feedback